Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antidepressant Treatment for HIV Risk Reduction in Depressed IV Drug Users
NCT00228007Phase 3Completed
- Sponsor
- Butler Hospital
- Start
- Sep 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of antidepressant (TDDS/ODF) in major depressive disorder (MDD), sponsored by Butler Hospital. Started Sep 2000; status: completed.
02
Drugs
antidepressant (TDDS/ODF)
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00228007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00228007.